Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

IV fluids recalled over possible contamination—patients face risk of vascular complications
Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.
FDA warns public about vascular device after 3 deaths
The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.
Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform
Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.
Medtronic leads $100M investment in artery denervation company
Pulnovo Medical, a global medtech company, plans on using the funds for clinical development, regulatory submissions, commercialization and much more.
FDA clears next-gen hybrid system for intravascular imaging
Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Interventional cardiologists take on angiography-derived physiology in new expert opinion

ADP offers care teams multiple benefits not seen with traditional wire-based physiologic assessments. A roundtable of 17 expert clinicians discussed the topic at length, and their findings were used to develop a new manuscript published in JSCAI.

New injectable therapy could help limit brain damage in stroke patients

Early research suggests a single injection could reduce both brain damage and inflammation if delivered after a patient experiences a stroke. Much more research is still needed, but the new therapy showed significant potential.

Samir B. Pancholy, MD, chief interventional cardiologist, Wayne Memorial Hospital in Honesdale, Pennsylvania, discusses the differences in the business models for office based labs (OBL) vs ambulatory surgical centers (ASC) and choosing the right model cardiovascular and vascular procedures. #TCT #SCAI #OBL #ASC

Cardiologist highlights key differences between OBLs and ASCs

Current payment policies have health systems and physicians all over the country looking to learn more about these two business models.

Faster treatments, better outcomes: 5 key takeaways from new stroke guideline

The American Stroke Association's first major update in 7 years highlights the importance of coordinated care and expands patient access to critical treatments. It also includes the first detailed recommendations for treating stroke in pediatric patients.

Advances in calcified coronary plaque modification are increasingly centered on intravascular lithotripsy (IVL) because the technology reduces complications such as vessel trauma and perforation associated with traditional high-pressure balloons or atherectomy techniques. Cardiovascular Business spoke with Samin K. Sharma, MD, director of the Mount Sinai Fuster Heart Hospital Cardiovascular Clinical Institute, recently about the advances in IVL. #IVL #TCT

Exploring major trends as IVL keeps evolving

Intravascular lithotripsy is expected to see even wider adoption when lower-profile catheters are introduced and device costs start to drop, explained Samin Sharma, MD.

Vascular surgeon accused of double murder pleads not guilty

The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.

The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.

IVL competition heats up as Boston Scientific enters US market

Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

Treating CLTI with atherectomy fails to improve outcomes—is it worth the cost?

Atherectomy is associated with rising healthcare costs, making it important to learn as much about the procedure's long-term value as possible.

Vascular & Endovascular

IV fluids recalled over possible contamination—patients face risk of vascular complications

FDA warns public about vascular device after 3 deaths

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Medtronic leads $100M investment in artery denervation company

FDA clears next-gen hybrid system for intravascular imaging